Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amicus: Bullish Options Trade Into Clinical Trial Catalysts
TheStreet.com
Tuesday, December 4, 2012 - 1:36pm
tags:
Amicus, clinical trials, Amigal
Biotech's Comeback Kid
Forbes
Tuesday, December 4, 2012 - 1:35pm
tags:
Biogen Idec, George Scangos, Genentech
ImmunoGen's Press Release Is More Than Mere News
Seeking Alpha
Tuesday, December 4, 2012 - 1:33pm
tags:
Immunogen, Targeted Antibody Payload
NPS Pharma Drifts Higher On Potential Orphan Drug Approval
Seeking Alpha
Tuesday, December 4, 2012 - 1:33pm
tags:
NPS Pharmaceuticals, orphan drugs, short bowel syndrome, Gattex
Drug industry treading water on R&D productivity
Reuters
Tuesday, December 4, 2012 - 12:10pm
tags:
R&D
Are Allergan and Orexigen Warming Up?
Motley Fool
Tuesday, December 4, 2012 - 12:09pm
tags:
Allergan, Orexigen
Forest Labs Sued By Doctor For Sending Junk Faxes
Pharmalot
Tuesday, December 4, 2012 - 12:02pm
tags:
Forest Labs, physicians
Sucampo Drops After FDA Delays Amitiza Decision
Bloomberg
Tuesday, December 4, 2012 - 12:01pm
tags:
FDA, Sucampo, Amitiza
Baxter Agrees to Buy Sweden’s Gambro for $4 Billion
Bloomberg
Tuesday, December 4, 2012 - 11:59am
tags:
Baxter, Sweden, Gambro, M&A
U.S. Barred From Prosecuting Off-Label Sales of Drugs
Bloomberg
Tuesday, December 4, 2012 - 11:57am
tags:
off-label
Why Has Pfizer Begun Layoffs?
Wall St. Cheat Sheet
Tuesday, December 4, 2012 - 11:55am
tags:
Pfizer, layoffs
Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity
Bloomberg
Tuesday, December 4, 2012 - 11:55am
tags:
GSK, GLP-1 agonist, obesity, diabetes, albiglutide, Victoza, Novo Nordisk
Discussing Amarin's Vascepa And GlaxoSmithKline's Lovaza With Omthera Pharma
Seeking Alpha
Tuesday, December 4, 2012 - 11:54am
tags:
Amarin, Vascepa, GSK, Lovaza, Omthera
Acadia Hits Home Run In Phase III Trial And Brings Market Focus To Parkinson's
Seeking Alpha
Tuesday, December 4, 2012 - 11:53am
tags:
Acadia, Parkinson's Disease, pimavanserin
U.S. top court rejects appeal of Kentucky Fen-Phen lawyer
Reuters
Monday, December 3, 2012 - 11:20am
tags:
Fen-Phen, Kentucky, Pfizer
Novartis Moving Forward In Generics
Seeking Alpha
Monday, December 3, 2012 - 11:19am
tags:
Novartis, generics, Pfizer, Teva
Bill suggests wholesale pricing to fight drug shortages
Fierce Pharma
Monday, December 3, 2012 - 10:54am
tags:
drug pricing, drug shortages, generics, injectables
Pfizer And The Incredible Shrinking Sales Force
Pharmalot
Monday, December 3, 2012 - 10:53am
tags:
Pfizer, drug reps, layoffs
Upcoming AML Treatments - Which Company Will Fly?
Seeking Alpha
Monday, December 3, 2012 - 10:49am
tags:
AML, Celgene, Cyclacel, Sunesis, acute myeloid leukemia
Vertex says Health Canada approves KALYDECO
The Fly on the Wall
Monday, December 3, 2012 - 10:47am
tags:
Canada, Kalydeco, Vertex Pharma, cystic fibrosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.